FDA approves first gene therapy for rare immune disorder

Dec 9 (Reuters) – The ‍U.S. Food and ‌Drug ‌Administration said on Tuesday it ​had ‍approved ​the ​first ‍gene therapy for a ‍rare and life-threatening ‍immune ‍disorder.

(Reporting ​by ​Sahil ⁠Pandey in ‌Bengaluru; Editing by Maju ⁠Samuel)